Multiple factors contribute to the decision not to take osteoporosis medications, with fear of adverse events topping the list, say researchers in a paper published online in the Journal of the American Pharmacists Association.

In the study, researchers collected information about 790 participants in the Patient Activation After DXA Result Notification study who had received prescriptions for new or different osteoporosis medications after a dual-energy X-ray absorptiometry scan. Participants were interviewed at baseline and 12 and 52 weeks after their DXA scans, and researchers collected information such as patient demographics, health history, health habits, prior osteoporosis diagnosis or treatment, osteoporosis knowledge using the “Osteoporosis and You” scale, osteoporosis health beliefs, and osteoporosis self-efficacy.

Read the rest of this blog on Micha Abeles’ website here.

Advertisements